https://www.selleckchem.com/products/dynasore.html
There are few studies developing a scoring system for short-term survival of patients with gynecologic malignancy. Seventy-three terminally ill patients with gynecologic malignancy who were admitted to our palliative care unit (PCU) from June 2009 to February 2018 were included. We accumulated routine blood data within 3months before PCU discharge. Receiver-operating characteristic analysis was performed on each blood factor, and area under the curve (AUC) was calculated to determine the predictive value for 14-day survival after the b
Like
Comment
Share
